MATMED aims to effect major positive impacts on health and wellbeing in the North-West Europe region by breaking down the barriers that prevent product innovations from reaching both patients and the wider population. The programme supports SMEs working in the fields of Advanced Materials, Medical Devices and Regenerative Medicine, enables high-quality transnational collaborations, and accelerates commercialisation in these medical areas.
It does this by providing:
- An online transnational network connecting SMEs, other companies, academia, research centres, regulatory, healthcare actors and investors.
- Support for SMEs to accelerate innovation, validate new product opportunities and demonstrate new technology through Voucher funding
- Advice for SMEs on the new regulatory framework for medical devices taking effect from 2020
- Help for suitable SMEs to find private investment, typically from business angels, to enable their innovations to be commercialised
MATMED aims to effect major positive impacts on health and wellbeing in the North-West Europe region by breaking down the barriers that prevent product innovations from reaching both patients and the wider population.
It supports SMEs working in the fields of Advanced Materials, Medical Devices and Regenerative Medicine, enables high-quality transnational collaborations, and accelerates commercialisation in these medical areas.
See below to read how MATMED also benefits large companies, research centres and academia, investors and regulatory framework experts.
What does MATMED offer?
As well as a transnational network - join it here - MATMED provides Voucher funding to fuel innovation, validate new product opportunities and demonstrate new technology. You can also receive advice on the 2020 regulatory framework for medical devices. And access to an extensive network of private investment.
Who is MATMED for?
The MATMED acceleration programme will open up new collaboration and commercialisation opportunities for your business. We understand that SMEs which are developing innovative MedTech products often need to collaborate with experts in a number of disciplines in order to speed up product development and reduce time to market, but find it hard to locate and connect with the right partners… and also access appropriate funding. This is where MATMED can help.
The Directory connects you with key innovators in the MedTech sector. It is easy to use, free to access, and enables collaborative projects between public research organisations, investors, start-ups and SMEs – to conduct validation studies, obtain funding and facilitate market access.
On top of this, the MATMED acceleration programme provides micro funding to undertake specific collaborative projects, and gives access to expert advice to help you adapt to the new EU regulation on medical devices and in-vitro diagnostics.
SMEs represent 99% of all businesses in the EU. Not sure if your advanced materials or medical device organisation is an SME? Try the European Commission’s self-assessment questionnaire here
MATMED is specifically aimed at the MedTech sector across North West Europe, and brings together some of Europe’s key innovators, experts and specialists all in one place. It is the ideal environment for large companies operating in the fields of advanced materials, medical devices and regenerative medicine to connect with innovators in the industry and identify the latest innovative technologies.
The MATMED network provides opportunities to directly connect with key innovators in the MedTech sector and supports industry-wide players to source early stage product development assets.
Research centres and academia
MATMED's transnational network will open up fresh and relevant opportunities for research collaborations with industry. Unlike existing business engagement platforms, the MATMED Directory links you with a large network of companies that are either innovating or already commercialising in the same scientific fields.
Easy to use and free to access, the portal connects you with relevant contacts from SMEs and larger businesses, who are open to raising project proposals together, co-applying research or innovation grants, and setting up long-term collaborations.
As well as this, MATMED also contains a pool of expertise, including regulatory advisors and private investors – who all can contribute into an industry-academia collaboration project – and supplies expert advice on R&D challenges, market needs and regulation changes.
The MATMED transnational network will give you early investment opportunities in high potential companies in the up and coming MedTech market. Unlike existing investment platforms, groups and academic hubs, the MATMED Directory provides access to innovative SMEs and researchers with a focus in this specialist area.
Easy to use and free to access, the directory connects you with relevant contacts from SMEs and larger businesses, which are open to raising project proposals together, co-applying research or innovation grants, and setting up long-term collaborations.
Register now if you are interested in investing in companies active in the field of high-tech materials for medical applications, willing to invest in early stage and growing SME companies, and looking for an investment ready proposition supported by MATMED experts.
Regulatory framework experts
MATMED will connect you to a whole transnational network of medical technology companies looking for your expertise. It has has been set up by leaders in the fields of advanced materials, medical devices and regenerative medicine across North West Europe, in order to boost innovation in the sector.
At its centre sits an exclusive online Directory of SMEs, academic research centres, investors, regulation experts and legal consultants. Advert-free, easy to use, and free of charge, the MATMED Directory is the only one of its kind, offering unique opportunities for transnational knowledge sharing and collaboration.
As well as promoting your services within the MedTech ecosystem, you will be able to connect to SMEs that are facing significant challenges adapting to the new EU regulation on medical devices and in-vitro diagnostics. On top of this, you will also have opportunities to participate in supporting SMEs to understand how to comply with EU requirements to market their products in Europe.
LEAD PARTNER ORGANISATION
GM Business Support Ltd
- Center for NanoTechnology (CeNTech) Ltd.
- Development Company East Netherlands NV (East NL)
- Ghent University
- The University of Manchester
- Aachen-Maastricht Institute for Biobased Materials (Maastricht University)
- Netzwerk Gesundheitswirtschaft Münsterland
- Forschungszentrum Jülich
MATMED is a project within the INTERREG North-West Europe Programme. INTERREG North-West Europe falls under the European Cohesion Policy and is financed by the European Regional Development Fund (ERDF).